CHICAGO--(EON: Enhanced Online News)--Presenting significant improvements to cardiac MR imaging, Toshiba Medical’s Vantage Titan™ 1.5T / cS Edition with M-Power™ V3.6 software has received FDA clearance. The new system retains all the patient-friendly features of the Vantage Titan 1.5T MR with added technology to simplify complex cardiac exams.
“Toshiba Medical understands the patient experience and business needs of MR, and the Vantage Titan / cS Edition offers customers innovative MR imaging solutions that meet a variety of clinical needs, without compromising patient satisfaction.”
The Vantage Titan / cS Edition offers cardiologists and radiologists a comprehensive suite of innovative applications to help them improve their workflow and patient comfort:
- SUREVOITM with CardioLine+ (Option): The system offers SUREVOI Cardiac anatomy recognition technology to automatically determine the position of the heart. The enhanced CardioLine application CardioLine+ works with SUREVOI to automatically detect anatomical landmarks for accurate and reproducible positioning to complete alignment of 14 standard cardiac views with minimal operator interaction.
- Multi b-Value Diffusion: The Vantage Titan / cS Edition allows acquisition of multiple b-values in a single scan enabling physicians to quickly identify tissue diffusivity.
- Multi-echo T2 Mapping: The system also supports Multi-echo T2 Mapping, enabling physicians to visualize T2 map cartilage images to aid them in making a diagnosis and determining if treatment is needed.
- Vitrea® Extend (Option): A state-of-the-art post-processing application, Vitrea Extend permits clinicians to complete post-processing at a separate workstation while allowing the next patient exam to be conducted at the MR system. The Vitrea Extend solution comes with expert packages powered by the latest post-processing applications made by Olea Medical and Medis.
“The Vantage Titan / cS Edition gives healthcare providers the ability to diversify their MR imaging offerings and reduce their exam times, creating a new opportunity for routine cardiac MR,” said Dominic Smith, senior director, CT, PET/CT, and MR Business Units, Toshiba America Medical Systems, Inc. “Toshiba Medical understands the patient experience and business needs of MR, and the Vantage Titan / cS Edition offers customers innovative MR imaging solutions that meet a variety of clinical needs, without compromising patient satisfaction.”
Toshiba Medical is showcasing the new Vantage Titan / cS Edition at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, November 27 – December 2, 2016 (Booth #7334, North Hall B).
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit Toshiba Medical’s website at www.medical.toshiba.com.
Vantage Titan, M-Power, and SUREVOI are trademarks of Toshiba Medical Systems Corporation.
Vitrea is a registered trademark of Vital Images Inc.